Vimarsana
Biggest News Aggregation in the World

Comorbidity Subgroups News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Comorbidity Subgroups. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Comorbidity Subgroups Today - Breaking & Trending Today

Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force | Breast Cancer | JAMA - Vimarsana News

Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force | Breast Cancer | JAMA

Published: April 30, 2024

This modeling study uses Cancer Intervention and Surveillance Modeling Network models and national data on breast cancer incidence, mammography

Source: jamanetwork.com
Related Topics:
United StatesUniversity Of TexasSarahm TemkinGil QuessepVan RavesteynYa Chen Tina ShihJulie McgregorYing LuMunoz MedinaLinn AbrahamHannah JohnsonAdela BiosciencesYifan LuAmy Trentham DietzElizabeth WebberDoug OwensThomas LawlerAmy KnudsenTracy WolffJillian HendersonJennie MartinClaudia SeguinJennifer CroswellMd Office Of Research On Women HealthUs Department Of Health
Tirzepatide Lowers Weight Across All Groups With Obesity - Vimarsana News

Tirzepatide Lowers Weight Across All Groups With Obesity

Published: November 7, 2022

The anti-obesity medication semaglutide (Wegovy) 'took things up one big notch, and now tirzepatide [which is still awaiting approval for weight loss] is up a little notch above that,' one expert commented.

Source: medscape.com
Related Topics:
New YorkUnited StatesNorthwestern UniversityChapel HillSriram MachineniPatrickm OneilRobertf KushnerEli LillyLouisj AronneDrug AdministrationUniversity Of North CarolinaAmerican Diabetes AssociationWeill Cornell Medical CollegeWeight Management CenterUniversity Of South CarolinaFeinberg School Of MedicineChair PatrickMedical UniversitySouth CarolinaMedscape Medical NewsComorbidity SubgroupsOverall QolFeinberg SchoolNew York CityNorth Carolina